Policy

The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer.

Hear from a policy manager at Cancer Research UK about what they think about Phillip Morris International’s bid for pharmaceutical company Vectura.

During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage.

Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role.

We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers

Over 11,000 cases of cancer were linked to smoking in the lowest income group, compared to around 6,000 in the highest.

Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity

The UK Government recently published their Life Sciences Vision, setting clear targets for supporting UK R&D. Cancer Research UK’s CEO, Michelle Mitchell, knows that it requires real investment.

Philip Morris International (PMI), the American tobacco company, and maker of Marlboro cigarettes, is buying Vectura, the British respiratory drugs company.

Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.